Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Randomised Controlled Trial of Intravitreal Triamcinolone in Diabetic Macular Oedema Refractory to Laser Treatment
2005-000397-45Phase 4Completed
- Sponsor
- Queen’s Medical Centre
- Start
- Mar 2005
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of triamcinolone in diabetic macular edema (DME) (2 arms), sponsored by Queen’s Medical Centre. Primary endpoints: Visual and anatomical outcomes over 6 months and Safety of intravitreal triamcinolone at 6 months. Started Mar 2005; status: completed.
02
Drugs
triamcinolone
03
Conditions
diabetic macular edema (DME)
Beyond the preview
Go deeper on 2005-000397-45.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-000397-45.